These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11407106)

  • 1. Medical therapy of neurocardiogenic syncope.
    Cadman CS
    Cardiol Clin; 2001 May; 19(2):203-13, v. PubMed ID: 11407106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology and management of neurocardiogenic syncope.
    Nair N; Padder FA; Kantharia BK
    Am J Manag Care; 2003 Apr; 9(4):327-34; quiz 335-6. PubMed ID: 12703677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategy for the management of vasovagal syncope.
    Bloomfield DM
    Drugs Aging; 2002; 19(3):179-202. PubMed ID: 12027777
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Syncope: pathophysiology, diagnosis, and pharmacotherapy.
    Lazarus JC; Mauro VF
    Ann Pharmacother; 1996 Sep; 30(9):994-1005. PubMed ID: 8876862
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of vasovagal syncope.
    Atiga WL; Rowe P; Calkins H
    J Cardiovasc Electrophysiol; 1999 Jun; 10(6):874-86. PubMed ID: 10376927
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurocardiogenic syncope: latest pharmacological therapies.
    Chen LY; Shen WK
    Expert Opin Pharmacother; 2006 Jun; 7(9):1151-62. PubMed ID: 16732702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical practice. Neurocardiogenic syncope.
    Grubb BP
    N Engl J Med; 2005 Mar; 352(10):1004-10. PubMed ID: 15758011
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in plasma epinephrine concentration and in heart rate during head-up tilt testing in patients with neurocardiogenic syncope: correlation with successful therapy with beta-receptor antagonists.
    Klingenheben T; Kalusche D; Li YG; Schöpperl M; Hohnloser SH
    J Cardiovasc Electrophysiol; 1996 Sep; 7(9):802-8. PubMed ID: 8884509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurocardiogenic syncope in children : current concepts in diagnosis and management.
    Massin M
    Paediatr Drugs; 2003; 5(5):327-34. PubMed ID: 12716219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The management of vasovagal syncope.
    Parry SW; Kenny RA
    QJM; 1999 Dec; 92(12):697-705. PubMed ID: 10581332
    [No Abstract]   [Full Text] [Related]  

  • 11. Dysautonomia and neurocardiogenic syncope.
    McLeod KA
    Curr Opin Cardiol; 2001 Mar; 16(2):92-6. PubMed ID: 11224639
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The use of methylphenidate in the treatment of refractory neurocardiogenic syncope.
    Grubb BP; Kosinski D; Mouhaffel A; Pothoulakis A
    Pacing Clin Electrophysiol; 1996 May; 19(5):836-40. PubMed ID: 8734752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical efficacy of propantheline bromide in neurocardiogenic syncope: pharmacodynamic implications.
    Yu JC; Sung RJ
    Cardiovasc Drugs Ther; 1997 Jan; 10(6):687-92. PubMed ID: 9110111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of paroxetine hydrochloride, a selective serotonin reuptake inhibitor, on refractory vasovagal syncope: a randomized, double-blind, placebo-controlled study.
    Di Girolamo E; Di Iorio C; Sabatini P; Leonzio L; Barbone C; Barsotti A
    J Am Coll Cardiol; 1999 Apr; 33(5):1227-30. PubMed ID: 10193720
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of neurocardiogenic syncope.
    Grubb BP; Karas B
    Curr Opin Cardiol; 1998 Jan; 13(1):29-35. PubMed ID: 9559254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vasodepressor syncope. Diagnosis and management.
    Barbey JT
    Cardiol Clin; 1997 May; 15(2):251-6. PubMed ID: 9164713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A review of pathophysiology and therapy of patients with vasovagal syncope.
    White CM; Tsikouris JP
    Pharmacotherapy; 2000 Feb; 20(2):158-65. PubMed ID: 10678294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The medical therapy of cardioinhibitory syncope in pediatric patients.
    Deal BJ; Strieper M; Scagliotti D; Hulse E; Auld D; Campbell R; Strasburger JF; Benson DW
    Pacing Clin Electrophysiol; 1997 Jul; 20(7):1759-61. PubMed ID: 9249828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective evaluation of a two-step therapeutic strategy in neurocardiogenic syncope: midodrine as second line treatment in patients refractory to beta-blockers.
    Klingenheben T; Credner S; Hohnloser SH
    Pacing Clin Electrophysiol; 1999 Feb; 22(2):276-81. PubMed ID: 10087541
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological treatment of reflex syncope.
    Kaufmann H; Freeman R
    Clin Auton Res; 2004 Oct; 14 Suppl 1():71-5. PubMed ID: 15480933
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.